GS Paper: GS3-17.Awareness in the fields of IT, Space, Computers, Robotics, Nano-technology, Bio-technology and issues relating to Intellectual Property Rights.

Central Idea

• In a momentous development in the fight against malaria, the World Health Organization (WHO) issued a recommendation for the R21/Matrix-M malaria vaccine on October 2.
• This pioneering vaccine, developed by the University of Oxford and manufactured by India’s Serum Institute, has already gained approval for use in children under 36 months in Nigeria, Ghana, and Burkina Faso.

R21/Matrix-M Vaccine

• Extensive Testing: The vaccine’s efficacy was rigorously assessed in a phase-3 trial involving 4,800 children across five sites in Mali, Burkina Faso, Kenya, and Tanzania. These sites vary in malaria transmission intensity and seasonality.
• Blind Trial: Participants were randomly assigned to receive either the malaria vaccine or a control (approved rabies vaccine) in a double-blind study, ensuring impartiality.
• Multi-Dose Regimen: The vaccination schedule comprised three doses administered 4 weeks apart, with a booster shot administered 12 months after the last dose.
• Strategic Timing: Primary vaccinations occurred before the malaria season in seasonal transmission regions or at any time of the year in perennial transmission regions.

Impressive Results

• According to preprint data (pending peer review), the vaccine demonstrated a remarkable efficacy of 75% in children aged 5-36 months in seasonal malaria regions and 68% in perennial malaria regions after one year.
•  Notably, children aged 5-17 months, more vulnerable to severe malaria, exhibited even higher vaccine efficacy of 79% in seasonal regions and 75% in perennial regions.
• Vaccine efficacy remained substantial for 18 months, further reinforced by a booster dose administered 12 months after the primary series.

Seasonality Matters

• Optimal Timing: Results suggest that the vaccine performs more effectively in regions with seasonal malaria compared to perennial transmission areas.
• Seasonal Patterns: In seasonal sites, 82% of malaria episodes occurred in the first six months of follow-up, while only 26% occurred in the initial six months in perennial sites.
• Vaccination Timing: Since the vaccine is administered just before the malaria season, its protection is more pronounced when malaria is seasonal.

Central Idea

• The 2023 Nobel Prize in Chemistry has been awarded to Moungi G. Bawendi, Louis E. Brus and Alexei I. Ekimov for the discovery and synthesis of quantum dots.

About the Nobel Laureates

• Alexei Ekimov: Born in 1945 in the former USSR, Ekimov earned his PhD in 1974 from Ioffe Physical-Technical Institute. He was formerly the Chief Scientist at Nanocrystals Technology Inc., New York, USA.
• Louis Brus: Born in 1943 in Cleveland, USA, Brus obtained his PhD in 1969 from Columbia University, where he is a professor.
• Moungi Bawendi: Born in 1961 in Paris and raised in France, Tunisia, and the US, Bawendi earned his PhD in 1988 from the University of Chicago. He is a professor at the Massachusetts Institute of Technology (MIT), USA.

What are Quantum Dots?

• Quantum dots (QDs) are man-made nanoscale crystals celebrated for their unique optical and electronic properties.
• They can transport electrons and emit diverse colors when exposed to UV light.
• These artificially synthesized semiconductor nanoparticles found their origins in theoretical concepts in the 1970s, followed by successful synthesis in the early 1980s.
• Small semiconductor particles exhibit quantum effects, altering their optical properties based on size.

Working Principle

• Size Matters: Quantum dots manipulate light emission based on size, as energy levels are linked to wavelength (color). By controlling particle size, they can emit or absorb specific colors of light.
• Versatile Structures: Quantum dots come in diverse forms, with properties determined by factors like size, shape, composition, and structure. They can be employed as active materials in single-electron transistors and offer vast application potential.

Contributions of Ekimov, Brus, and Bawendi

• Ekimov’s Soviet Discovery: Ekimov’s initial discoveries in this field, dating back to 1981, were pioneering but remained largely unknown due to the Iron Curtain’s restrictions.
• Glass Coloration Mystery: Ekimov’s work began with the curious phenomenon of glass coloration. He explored how particle size influenced the color imparted to glass during its formation, leading to a size-dependent quantum effect discovery.
• Brus’s Independent Revelation: Unaware of Ekimov’s work, Brus, in the U.S., was working with cadmium sulfide particles to harness solar energy. He observed that smaller particles absorbed light at different wavelengths, demonstrating the size-dependent quantum effect.
• Bawendi’s Innovations: Bawendi improved particle creation methods, enhancing the perfection of nanocrystals and enabling the exploration of quantum dots’ unique properties by more chemists.

Applications of Quantum Dots

• In Electronics: Quantum dots play a crucial role in QLED technology, used in computer and television screens. They also adjust the light in LED lamps, offering various color temperatures.
• Biochemistry and Medicine: Quantum dots are used in biochemistry to map cells and organs, and doctors explore their potential for tracking tumor tissue in the body. Chemists leverage their catalytic properties to drive chemical reactions.

Central Idea

• Anne L’Huillier, Pierre Agostini, and Ferenc Krausz have been honored the 2023 Physics Nobel Prize for their groundbreaking experiments, providing humanity with new tools to explore the inner workings of electrons within atoms and molecules.

Measuring Rapid Electron Processes

• Tracking electron movement: Their work has enabled the creation of extremely short pulses of light, lasting only ato-seconds (1×10−18 of a second), allowing for the measurement of the lightning-fast processes through which electrons move or change energy.
• Observing Subatomic Motion: Electrons, the tiny particles that orbit the nucleus within atoms, move at astonishing speeds, making real-time observation impossible.
• High-Shutter-Speed Analogy: The trio’s research can be likened to a high-shutter-speed camera freezing motion to capture clear images. Similarly, they’ve achieved the ability to “freeze” electron movement using ultra-short light pulses.

Their Journey to Success

• Anne L’Huillier’s Discovery: In 1987, L’Huillier discovered that laser light waves interacting with noble gases could provide some electrons with extra energy, which was then emitted as light. She continued to develop this concept.
• Pierre Agostini’s Breakthrough: In 2001, Agostini successfully generated consecutive light pulses, each lasting just 250 attoseconds.
• Ferenc Krausz’s Contribution: Simultaneously, Krausz’s experiments isolated single light pulses lasting 650 attoseconds, providing invaluable insights into atomic processes.

Significance of their Work

• Unveiling Electron World: Atto-second physics, as their work is known, has opened doors to understanding mechanisms controlled by electrons.
• Eva Olsson’s Insight: According to Eva Olsson, Chair of the Nobel Committee for Physics, this breakthrough allows us to comprehend electron-driven phenomena and explore their practical applications.
• Potential Medical Application: Studying molecular-level changes in blood using these techniques could aid in disease identification.
• Advanced Electronics: A deeper understanding of electron can contribute to the development of more efficient electronic devices.